Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Ron Blankstein, MD, FACC, FASNC, MSCCT, FASPC, associate director, cardiovascular imaging program, director, cardiac computed tomography, Brigham and Women’s Hospital, and a professor of medicine and radiology, Harvard Medical School, explains why Medicare is proposing increased coronary computed tomography angiography (CCTA) payments to hospitals.

Higher payments for CCTA could bring considerable change to cardiology

Ron Blankstein, MD, explains how and why Medicare is proposing an increase to hospital payments for coronary CT angiography.

Thumbnail

Reduce, reuse, recycle: How cath labs can lower cardiology’s colossal carbon footprint

Cath labs, like radiology suites and operating rooms, are leading contributors to the world’s growing carbon footprint.

Thumbnail

FDA approves hydrogel to stop severe, life-threatening bleeding

Traumagel is applied to wounds using a syringe and can be used even on traumatic injuries, such as those from gunshots.

technologist MRI rad tech radiologic radiology

Rad tech advocates submit 42,000 comments to feds in push to gain ‘professional’ status

Every 10 years, the Office of Management and Budget reclassifies jobs as either “technical” or “professional,” with the window now open. 

Bharath Krishnamurthy, a director of Health Policy and Analytics at the American Hospital Association (AHA), explains explains how drug shortages and supply chain issues are negatively impacting U.S. healthcare.

Drug shortages jeopardize patient access to quality hospital care

American Hospital Association Director of Health Policy and Analytics Bharath Krishnamurthy explains how drug shortages and supply chain issues are negatively impacting U.S. healthcare.

money business cash flow dollar

White House unveils lower prices for popular heart, diabetes drugs after Medicare negotiations

Apixaban, empagliflozin, rivaroxaban and sacubitril/valsartan are just some of the medications included in this initial round of Medicare price negotiations. Their new prices were reduced by 56%, 66%, 62% and 53%, respectively. 

Medicare Money dollar payment reimbursement

Medicare negotiates lower price for 10 vital drugs, saving seniors $1.5B

The move will save the Medicare $6 billion in just one year, an announcement from the Biden administration said.

Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

Crisis averted: Recalled heart pumps found after being sent to customers by mistake

The FDA warned that the devices failed a safety inspection, but were still distributed for patient use. They have now all been located.